Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of herpes simplex].

R Engst1

  • 1Dermatologische Klinik und Poliklinik der TU München.

Zeitschrift Fur Hautkrankheiten
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Aciclovir, a nucleoside analog, effectively manages herpes simplex infections by shortening symptoms and lesions. Continuous oral aciclovir therapy for up to six months significantly suppresses recurrent genital herpes outbreaks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exaggerated onychodermal band: physiologic, triggered by nail plate infection, drug-induced or idiopathic?

Journal of the European Academy of Dermatology and Venereology : JEADV·2008
Same author

Primary manifestation of a zosteriform lichen planus: isotopic response following herpes zoster sine herpete?

The British journal of dermatology·2008
Same author

HHV8-positive Kaposi sarcoma in a long-term human immunodeficiency virus-exposed but uninfected patient carrying the CCR5-promoter mutation A59029G.

The British journal of dermatology·2005
Same author

Hourglass-like leuconychia in congenital lamellar ichthyosis.

The British journal of dermatology·2004
Same author

Internet advice in dermatology and allergy: 1 year analysis of telerequests and answers.

Dermatology online journal·2002
Same author

Famciclovir in treatment of acute herpes zoster: results of two post-marketing surveillance studies in Germany.

Acta dermato-venereologica·2001

Area of Science:

  • Virology
  • Pharmacology
  • Dermatology

Context:

  • Herpes simplex virus (HSV) infections pose significant health challenges.
  • Nucleoside analogs are a key therapeutic class for managing viral infections.
  • Aciclovir has demonstrated efficacy in treating HSV.

Purpose:

  • To evaluate the effectiveness of aciclovir in managing herpes simplex infections.
  • To assess the impact of continuous oral aciclovir therapy on recurrent genital herpes.

Summary:

  • Aciclovir, a nucleoside analog, is well-tolerated and effectively reduces the duration and severity of herpes simplex infection symptoms and lesions.
  • Sustained oral administration of aciclovir for up to six months significantly suppresses the recurrence of genital herpes in patients undergoing treatment.

Related Experiment Videos

Impact:

  • Establishes aciclovir as a reliable treatment option for herpes simplex.
  • Provides evidence for the long-term suppressive therapy of recurrent genital herpes with aciclovir.
  • Contributes to improved patient outcomes and quality of life for individuals with recurrent herpes infections.